NASDAQ:SLGL

Sol-Gel Technologies Q1 2025 Earnings Results & Report

Sol-Gel Technologies logo
$52.83 -2.13 (-3.88%)
Closing price 04:00 PM Eastern
Extended Trading
$52.56 -0.27 (-0.51%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sol-Gel Technologies reported Q1 2025 earnings on May 23, 2025. The company reported EPS of -$3.20, while revenue was $1.03 million.

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

Sol-Gel Technologies EPS Results

Actual EPS
-$3.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 8 quarters

Sol-Gel Technologies Revenue Results

Actual Revenue
$1.03 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Earnings Documents

Sol-Gel Technologies Q1 2025 Earnings FAQ

Sol-Gel Technologies (NASDAQ:SLGL) reported earnings of -$3.20 per share for Q1 2025. The report was announced on Friday, May 23, 2025.

Sol-Gel Technologies reported revenue of $1.03 million for Q1 2025.

Sol-Gel Technologies Earnings Headlines

Contrasting Sol-Gel Technologies (SLGL) & Its Rivals
Don’t delete this, read it today
Porter Stansberry has spent more than 30 years studying the economy and financial markets, and says he has never felt pressure like this. He believes the foundations beneath our way of life have cracked. One Nobel Prize winner has warned that the force behind it threatens to divide America. Stansberry points to rising living costs, deepening division and building anger as signs. His documentary, The Final Displacement, names the force and outlines what he believes you can do about it now.tc pixel
Sol-Gel Technologies (SLGL) Projected to Release Earnings on Thursday
See More Sol-Gel Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sol-Gel Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sol-Gel Technologies and other key companies, straight to your email.

About Sol-Gel Technologies

Sol-Gel Technologies (NASDAQ:SLGL) is an Israel-based dermatology company that develops topical treatments for skin conditions. Its proprietary technology uses silica-based microencapsulation to formulate active ingredients for topical use.

The company’s products include Epsolay, a benzoyl peroxide cream approved in the United States for inflammatory lesions of rosacea, and Twyneo, a topical combination of tretinoin and benzoyl peroxide approved for acne vulgaris.

Sol-Gel has pursued commercialization and licensing opportunities in the United States and other markets. Its business also includes developing additional dermatology treatments using its formulation platform.

View Sol-Gel Technologies Profile